Purple Biotech Ltd. (PPBT) stock
PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.71+0.03 (+1.79%)
Close on Nov 17, 2026Market cap $1.59MP/E 0.0Yield –
Purple Biotech pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Purple Biotech's pe ratio was 0.0× on Nov 11, 2026, against 0.0× a year earlier. Over the last 5 years it ranged from 0.0× to 0.2×, with a median of 0.0×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.0× | +0.0 |
| 2025 | Dec 31, 2025 | 0.0× | −0.0 |
| 2024 | Dec 31, 2024 | 0.0× | −0.0 |
| 2023 | Dec 29, 2023 | 0.0× | +0.0 |
| 2022 | Dec 30, 2022 | 0.0× | −0.2 |
| 2021 | Dec 31, 2021 | 0.2× | −1.1 |
| 2020 | Dec 31, 2020 | 1.3× | −0.9 |
| 2019 | Dec 31, 2019 | 2.1× | +1.6 |
| 2018 | Dec 31, 2018 | 0.5× | −0.6 |
| 2017 | Dec 29, 2017 | 1.1× | +0.4 |
| 2016 | Dec 30, 2016 | 0.7× | – |
See a number that looks wrong?